The efficacy of N-acetyl cysteine as an adjunctive treatment for first episode psychosis

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1125778

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

First episode psychosis may foreshadow devastating, chronic illness. Psychosis follows a staged, progressive pathway. There is evidence to suggest illness progression can be diminished and perhaps even averted if appropriate treatments are given at the early stages of illness. This project will test if N-acetycysteine (NAC) administered to young people who have experienced a first episode of psychosis can help prevent this early psychotic experience from developing into a chronic disorder.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2022

Funding Scheme: Project Grants

Funding Amount: $2,143,069.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Psychiatry (incl. Psychotherapy)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

first episode | inflammation | oxidative stress | psychosis | schizophrenia and related disorders

Related Links